Post Operative AnalgesiaNCT07463482
Preoperative High-Dose Oral Paracetamol for Postoperative Analgesia in Children Undergoing Tonsillectomy"
A study testing Paracetamol (acetaminophen) in people with Post Operative Analgesia and Tonsillectomy With or Without Adenoidectomy, run by Thammasat University at 1 site in Thailand.
Trial summary
This randomized clinical trial compares two different preoperative doses of oral paracetamol (acetaminophen) in children undergoing elective tonsillectomy. The aim is to determine whether a higher loading dose (30 mg/kg) decreases the need for opioid rescue medication after surgery compared with the standard dose (15… Read more about this study
- Who is it for?
- Ages 3 to 15 years
- Conditions the study is for
- Post Operative Analgesia, Tonsillectomy With or Without Adenoidectomy
- What is being tested?
- Paracetamol (acetaminophen)
- Type of treatment
- Pill or oral medicine
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 54 participants
- Where
- 1 siteThailand
- Study dates
- Mar 2026to Nov 2026
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 3 to 15 years
- All sexes
- No healthy volunteers
- Child
Who may be able to join
- Children aged 3 to 15 years
- ASA physical status I-III
- Scheduled for elective tonsillectomy with or without adenoidectomy
Who cannot join
- Known allergy or contraindication to paracetamol or any agents in the study protocol
- Chronic opioid use
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Thailand1 site
Thammasat University
Pathum Thani, Changwat Pathum Thani, 12120
Waranya Lertpaitoonpan, MD, +66892039291, waranya.anesthtu@gmail.com
About this study
Official title: Effect of Preoperative Oral Paracetamol Loading Dose Versus Standard Dose on Postoperative Opioid Consumption in Pediatric Tonsillectomy With Multimodal Analgesia: A Randomized Controlled Trial
This randomized clinical trial compares two different preoperative doses of oral paracetamol (acetaminophen) in children undergoing elective tonsillectomy. The aim is to determine whether a higher loading dose (30 mg/kg) decreases the need for opioid rescue medication after surgery compared with the standard dose (15 mg/kg), when used as part of a multimodal pain management approach. Children aged 3 to 15 years will be randomly assigned to receive either 30 mg/kg or 15 mg/kg of oral paracetamol before surgery. All participants will receive the same standard anesthesia and postoperative pain management. The primary outcome is the total amount of rescue opioid (fentanyl) required during the first 12 hours after surgery. Secondary outcomes include postoperative pain scores and the occurrence of side effects such as nausea and vomiting. This study seeks to determine whether a higher initial dose of paracetamol offers additional clinical benefits in pediatric tonsillectomy with multimodal analgesia.
Read the detailed description
Tonsillectomy is one of the most commonly performed surgical procedures in children, yet it is often associated with significant postoperative pain. Effective pain management is critical to minimizing complications, and a multimodal approach to analgesia is recommended to reduce opioid consumption while providing effective pain relief. Paracetamol is a widely used and safe analgesic component within these multimodal regimens.
While previous studies indicate that an oral paracetamol loading dose of 30 mg/kg effectively reduces fever and provides consistent serum levels, there remains a limited direct comparison of clinical outcomes between an oral preoperative loading dose and a standard dose within preemptive standardized multimodal analgesia protocols for pediatric tonsillectomy. This randomized controlled trial aims to evaluate whether an oral paracetamol loading dose yields a superior opioid-sparing effect compared to a standard dose in this patient population.
A total of 54 pediatric patients, aged 3 to 15 years with ASA physical status I-III, scheduled for elective tonsillectomy (with or without adenoidectomy) will be enrolled. Participants will be randomized in a 1:1 ratio into two groups:
Group L (Loading Dose): Will receive a preoperative oral paracetamol dose of 30 mg/kg (adjusted body weight, maximum 1000 mg) 30-60 minutes before anesthesia induction.
Group C (Standard Dose): Will receive a preoperative oral paracetamol dose of 15 mg/kg (maximum 1000 mg) 30-60 minutes before anesthesia induction.
To maintain strict quadruple blinding, both groups will receive the same commercial paracetamol syrup formulation (250 mg/5 mL) prepared in opaque oral syringes by independent research staff. Participants, caregivers, treating anesthesiologists, surgeons, and outcome assessors (ward nurses) will be blinded to the group allocation.
All participants will undergo general anesthesia with endotracheal intubation and receive a standardized multimodal analgesia protocol. This protocol includes preoperative ibuprofen (10 mg/kg), intraoperative IV dexamethasone (0.2 mg/kg), local infiltration with 1% lidocaine with epinephrine, IV ondansetron (0.1 mg/kg), and postoperative oral paracetamol (15 mg/kg every 6 hours), ibuprofen (10 mg/kg every 8 hours).
Postoperative pain will be evaluated using age-appropriate validated tools: the revised FLACC scale for children aged 3-7 years (or those with cognitive impairment) and the Numerical Rating Scale (NRS) for children aged 7-15 years. Pain assessments will occur upon arrival at the post-anesthesia care unit (PACU) (hour 0), before transfer to the ward (hour 1), and at 6 and 12 hours postoperatively on the ward. If a patient reports a pain score of 4 or greater, rescue IV fentanyl (0.25 mcg/kg) will be administered according to protocol guidelines.
The primary outcome of the study is the total postoperative opioid (fentanyl) consumption within the first 12 hours after surgery. Secondary outcomes include postoperative pain scores at multiple time points, time to first rescue opioid requirement, the number of rescue opioid doses administered, and the incidence of adverse events such as nausea, vomiting, and sedation. The observation window is confined to the initial 12 hours post-surgery because most patients are discharged within 24 hours without oral opioid prescriptions, and the drug's pharmacological effects are expected to be most pertinent during this early recovery phase.
- Being tested
- Paracetamol (acetaminophen)
- Keywords
- paracetamol, acetaminophen, tonsillectomy, postoperative analgesia, pediatric anesthesia, multimodal analgesia
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Paracetamol (acetaminophen)Drug
Oral paracetamol administered preoperatively as a single dose ( 15 mg/kg or 30 mg/kg, depending on assigned arm).
| Study group | Role | What they receive |
|---|---|---|
| High-dose oral paracetamol (30 mg/kg) | Experimental | Participants receive oral paracetamol 30 mg/kg approximately 30-60 minutes before surgery. Receives: Drug: Paracetamol (acetaminophen) |
| Standard-dose oral paracetamol (15 mg/kg) | Active comparator | Participants receive oral paracetamol 15 mg/kg approximately 30-60 minutes before surgery. Receives: Drug: Paracetamol (acetaminophen) |
What is being measured
The primary outcome is the main question the study is designed to answer.
Total postoperative opioid consumption
Total postoperative opioid consumption (expressed as cumulative IV fentanyl dose in mcg/kg) was administered.
Measured: 0-12 hours after surgery
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted11 Mar 2026
- Study startMar 2026 (estimated)
- Primary completionSep 2026 (estimated)
- Study completionNov 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Post Operative AnalgesiaStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Quadruple blind
- Who is masked
- Participant, Care provider, Investigator, Outcomes assessor
- Enrolment
- 54 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Thammasat University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Waranya Lertpaitoonpan, Thammasat University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07463482
- Sponsor's protocol ID
- MTU-EC-AN-0-306/68
- Status last verified
- Mar 2026
- First submitted
- 5 Mar 2026
- Last updated
- 11 Mar 2026
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 11 Mar 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effect of Preoperative Oral Paracetamol Loading Dose Versus Standard Dose on Postoperative Opioid Consumption in Pediatric Tonsillectomy With Multimodal Analgesia: A Randomized Controlled Trial
- ClinicalTrials.gov ID
- NCT07463482
- Acronym / sponsor ID
- MTU-EC-AN-0-306/68
- Keywords
- paracetamol, acetaminophen, tonsillectomy, postoperative analgesia, pediatric anesthesia, multimodal analgesia
- Study type
- Interventional
- Recruitment status
- Not yet recruiting
- Enrolment
- 54 participants (estimated)
- Lead sponsor
- Thammasat UniversityUniversity, hospital or other
- Study start
- Mar 2026 (estimated)
- Primary completion
- Sep 2026 (estimated)
- Study completion
- Nov 2026 (estimated)
- First posted
- 11 Mar 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This randomized clinical trial compares two different preoperative doses of oral paracetamol (acetaminophen) in children undergoing elective tonsillectomy. The aim is to determine whether a higher loading dose (30 mg/kg) decreases the need for opioid rescue medication after surgery compared with the standard dose (15 mg/kg), when used as part of a multimodal pain management approach. Children aged 3 to 15 years will be randomly assigned to receive either 30 mg/kg or 15 mg/kg of oral paracetamol before surgery. All participants will receive the same standard anesthesia and postoperative pain management. The primary outcome is the total amount of rescue opioid (fentanyl) required during the first 12 hours after surgery. Secondary outcomes include postoperative pain scores and the occurrence of side effects such as nausea and vomiting. This study seeks to determine whether a higher initial dose of paracetamol offers additional clinical benefits in pediatric tonsillectomy with multimodal analgesia.
Detailed description
Tonsillectomy is one of the most commonly performed surgical procedures in children, yet it is often associated with significant postoperative pain. Effective pain management is critical to minimizing complications, and a multimodal approach to analgesia is recommended to reduce opioid consumption while providing effective pain relief. Paracetamol is a widely used and safe analgesic component within these multimodal regimens.
While previous studies indicate that an oral paracetamol loading dose of 30 mg/kg effectively reduces fever and provides consistent serum levels, there remains a limited direct comparison of clinical outcomes between an oral preoperative loading dose and a standard dose within preemptive standardized multimodal analgesia protocols for pediatric tonsillectomy. This randomized controlled trial aims to evaluate whether an oral paracetamol loading dose yields a superior opioid-sparing effect compared to a standard dose in this patient population.
A total of 54 pediatric patients, aged 3 to 15 years with ASA physical status I-III, scheduled for elective tonsillectomy (with or without adenoidectomy) will be enrolled. Participants will be randomized in a 1:1 ratio into two groups:
Group L (Loading Dose): Will receive a preoperative oral paracetamol dose of 30 mg/kg (adjusted body weight, maximum 1000 mg) 30-60 minutes before anesthesia induction.
Group C (Standard Dose): Will receive a preoperative oral paracetamol dose of 15 mg/kg (maximum 1000 mg) 30-60 minutes before anesthesia induction.
To maintain strict quadruple blinding, both groups will receive the same commercial paracetamol syrup formulation (250 mg/5 mL) prepared in opaque oral syringes by independent research staff. Participants, caregivers, treating anesthesiologists, surgeons, and outcome assessors (ward nurses) will be blinded to the group allocation.
All participants will undergo general anesthesia with endotracheal intubation and receive a standardized multimodal analgesia protocol. This protocol includes preoperative ibuprofen (10 mg/kg), intraoperative IV dexamethasone (0.2 mg/kg), local infiltration with 1% lidocaine with epinephrine, IV ondansetron (0.1 mg/kg), and postoperative oral paracetamol (15 mg/kg every 6 hours), ibuprofen (10 mg/kg every 8 hours).
Postoperative pain will be evaluated using age-appropriate validated tools: the revised FLACC scale for children aged 3-7 years (or those with cognitive impairment) and the Numerical Rating Scale (NRS) for children aged 7-15 years. Pain assessments will occur upon arrival at the post-anesthesia care unit (PACU) (hour 0), before transfer to the ward (hour 1), and at 6 and 12 hours postoperatively on the ward. If a patient reports a pain score of 4 or greater, rescue IV fentanyl (0.25 mcg/kg) will be administered according to protocol guidelines.
The primary outcome of the study is the total postoperative opioid (fentanyl) consumption within the first 12 hours after surgery. Secondary outcomes include postoperative pain scores at multiple time points, time to first rescue opioid requirement, the number of rescue opioid doses administered, and the incidence of adverse events such as nausea, vomiting, and sedation. The observation window is confined to the initial 12 hours post-surgery because most patients are discharged within 24 hours without oral opioid prescriptions, and the drug's pharmacological effects are expected to be most pertinent during this early recovery phase.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Quadruple blind (participant, care provider, investigator, outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| High-dose oral paracetamol (30 mg/kg) | Experimental | Drug: Paracetamol (acetaminophen)Participants receive oral paracetamol 30 mg/kg approximately 30-60 minutes before surgery. |
| Standard-dose oral paracetamol (15 mg/kg) | Active comparator | Drug: Paracetamol (acetaminophen)Participants receive oral paracetamol 15 mg/kg approximately 30-60 minutes before surgery. |
Who may qualify
- Ages
- 3 to 15 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child
Key inclusion criteria (3 listed)
- Children aged 3 to 15 years
- ASA physical status I-III
- Scheduled for elective tonsillectomy with or without adenoidectomy
Key exclusion criteria (2 listed)
- Known allergy or contraindication to paracetamol or any agents in the study protocol
- Chronic opioid use
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Paracetamol (acetaminophen)Oral paracetamol administered preoperatively as a single dose ( 15 mg/kg or 30 mg/kg, depending on assigned arm). | Drug | High-dose oral paracetamol (30 mg/kg), Standard-dose oral paracetamol (15 mg/kg) |
Primary outcome
Total postoperative opioid consumption
Time frame: 0-12 hours after surgery
Total postoperative opioid consumption (expressed as cumulative IV fentanyl dose in mcg/kg) was administered.
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 11 Mar 2026.
- Individual participant dataSharing planned: No
Related trials for Post Operative Analgesia
RecruitingPhase 4
ESP Blocks for Posterior Spinal Fusion
Postoperative Pain
Active, not recruiting
Efficacy of Laparoscopic-Assisted TAP Block in Laparoscopic Appendectomy
Appendectomy, Laparoscopic, Blockades Neuromuscular
RecruitingObservational study
Cryo NerVe Block Extremity AmputatioN RegIStry for Post Operative and pHantom Limb Pain
Amputation, Amputation of Lower Limb
Recruiting
Intravenous Dexamethasone (0 vs 4 vs 8 mg) as an Adjunct to PENG Block for Postoperative Analgesia in Total Hip Arthroplasty
Osteoarthritis, Hip, Hip Osteoarthritis
Not yet recruiting
Magnesium Sulphate as an Adjuvant in Combined Costoclavicular Block and Suprascapular Block Versus Interscalene Block for Ambulatory Shoulder Arthroscopy
Postoperative Pain, Shoulder Arthroscopy
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Paracetamol (acetaminophen) in people with Post Operative Analgesia and Tonsillectomy With or Without Adenoidectomy, run by Thammasat University at 1 site in Thailand.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 11 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Thailand. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Waranya Lertpaitoonpan, MD (+66892039291, waranya.anesthtu@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Total postoperative opioid consumption (time frame: 0-12 hours after surgery). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Mar 2026.